Neuberger Berman Group
EBS icon

Neuberger Berman Group’s Emergent Biosolutions EBS Stock Holding History

Neuberger Berman Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-686,449
Closed -$14.4M – 1812
2022
Q3 		$14.4M Buy
686,449
+36,348
+6% +$1.01M 0.02% 657
2022
Q2 		$20.2M Buy
650,101
+7,070
+1% +$241K 0.02% 621
2022
Q1 		$26.4M Sell
643,031
-3,364
-0.5% -$148K 0.02% 608
2021
Q4 		$27.8M Sell
646,395
-2,662,667
-80% -$120M 0.02% 608
2021
Q3 		$165M Sell
3,309,062
-109,544
-3% -$6.63M 0.14% 214
2021
Q2 		$214M Buy
3,418,606
+213,050
+7% +$13.7M 0.19% 154
2021
Q1 		$297M Sell
3,205,556
-5,793
-0.2% -$593K 0.28% 83
2020
Q4 		$287M Buy
3,211,349
+274,955
+9% +$25.2M 0.3% 81
2020
Q3 		$303M Sell
2,936,394
-52,079
-2% -$5.61M 0.36% 64
2020
Q2 		$236M Buy
2,988,473
+635,676
+27% +$47.4M 0.29% 87
2020
Q1 		$136M Sell
2,352,797
-98,040
-4% -$5.65M 0.21% 136
2019
Q4 		$132M Buy
2,450,837
+19,203
+0.8% +$1.04M 0.15% 198
2019
Q3 		$127M Buy
2,431,634
+215,081
+10% +$10M 0.16% 187
2019
Q2 		$107M Buy
2,216,553
+294,445
+15% +$14.1M 0.13% 236
2019
Q1 		$97.1M Buy
1,922,108
+617,486
+47% +$36.4M 0.12% 251
2018
Q4 		$77.3M Buy
1,304,622
+969,452
+289% +$62.5M 0.11% 274
2018
Q3 		$22.1M Buy
+335,170
New +$19.6M 0.03% 618

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Neuberger Berman Group's EBS Position: Q4 2022 in Review

Neuberger Berman Group sold out of Emergent Biosolutions (EBS) in Q4 2022, closing a stake of 686,449 shares — an estimated $14.4M sold.

Neuberger Berman Group first reported a position in EBS in Q3 2018 and held it in 17 quarters. The position peaked at $303M in Q3 2020. 196 funds tracked by Wall St. Rank hold EBS as of Q4 2022.

  • Neuberger Berman Group reported no remaining Emergent Biosolutions position as of Q4 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 686,449 Emergent Biosolutions shares in Q4 2022, an estimated $14.4M.
  • Neuberger Berman Group first reported a position in Emergent Biosolutions in Q3 2018 and held it in 17 quarters.
  • Neuberger Berman Group's Emergent Biosolutions position peaked at $303M in Q3 2020.
  • 196 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2022.

Based on Neuberger Berman Group's 13F filing for Q4 2022, filed 13 Feb 2023.